-

Veradigm Building Momentum Across All Markets

CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX) reports today strong fourth quarter new business results across all markets including the payer, life science, and provider markets.

The Veradigm Payer business added 6 net-new regional and national payer clients in Q4, representing +26% new business growth for the full year, along with expanding business among current clients, worth millions of dollars in total annual contract value. As healthcare evolves toward interoperability, Veradigm’s interoperability focused solutions are leading this effort among payers.

In the Veradigm Provider market, the company added 30 new revenue cycle management clients in the fourth quarter, contributing to over 200 percent year-over-year client growth. Additionally, the company’s clinical solutions continued to experience growth in the fourth quarter, adding a total of 484 new practices, across all solutions including many multi-specialty practices.

Veradigm Life Science continues to expand the utilization of its significant de-identified patient dataset with top tier life science companies, and commercial partners. During the fourth quarter more than 20 data, research study, and media agreements were signed. This momentum is partially being driven via the Veradigm Network and its strategic partnership with HealthVerity, a leader in privacy-protected data exchange.

As the Veradigm Network expands, Veradigm continues to integrate offerings to drive improved clinical and financial outcomes for its clients.

“Veradigm is well-positioned for growth because we offer unmatched connectivity, scale, data and expertise that is needed to address the challenges faced by healthcare providers, payers and the life sciences alike,” said Tom Langan, Veradigm President and Chief Commercial Officer.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

© 2023 Veradigm Inc. and/or its affiliates. All Rights Reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

Veradigm Inc.

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

More News From Veradigm Inc.

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom